Abstract
Session presented on: Friday, July 26, 2013:
Purpose: Adequate drug treatment for substance users continues to be a challenge for most United States (US) cities. In order to address heroin addiction in Baltimore, the Baltimore Buprenorphine Initiative (BBI) was implemented as a joint project to promote individualized, patient-centered buprenorphine therapy in conjunction with behavioral treatment to accelerate recovery from opioid addiction.
Methods: The BBI sample consisted of 1,039 subjects treated with buprenorphine and counseling between January 1, 2008 and June 1, 2009. Demographic and outcome variables were evaluated against two comparison groups of 8,692 patients receiving methadone treatment and 6,664 patients receiving intensive outpatient or standard outpatient (IOP-OP) treatment. Analytical methods were utilized to assess each of the three treatment groups in order to measure the simultaneous impact of a set of variables on an individual's LOS.
Results: The BBI sample consisted of 1,039 subjects treated between January 1, 2008 and June 1, 2009. Using analysis of variance, statistically significant differences among the groups were identified in three areas: age, lapse of time until admission to treatment, and length of stay in treatment. Controlling for age, gender, education, race, income, and employment, the following independent variables were used to predict LOS: lapse of time to admission, ASI scores, number of addictions, frequency of addictions, and group membership (BBI, methadone, or IOP). Demographic characteristics accounted for 15.8 % of the variance (R2 = 0.158) with the overall model explaining 42.6% of the variance surrounding the dependent variable LOS (R2=0.426). The model was statistically significant (F=223.51, df 18, 5413, p<0.001).
Conclusion: The findings of this study have practical implications for the design and implementation of heroin addiction programs. The research indicates that focusing on these specific predictive variables early in the program design phase could increase recovery success rates as measured by length of stay.
Sigma Membership
Unknown
Type
Presentation
Format Type
Text-based Document
Study Design/Type
N/A
Research Approach
N/A
Keywords:
Heroin, Drug Addiction, Buprenorphine
Recommended Citation
Murphy, Lyn Stankiewicz and Oros, Marla T., "The Baltimore Buprenorphine Initiative: A comparison of treatment modalities for addressing heroin addiction in an urban-based community" (2013). INRC (Congress). 201.
https://www.sigmarepository.org/inrc/2013/presentations_2013/201
Conference Name
24th International Nursing Research Congress
Conference Host
Sigma Theta Tau International
Conference Location
Prague, Czech Republic
Conference Year
2013
Rights Holder
All rights reserved by the author(s) and/or publisher(s) listed in this item record unless relinquished in whole or part by a rights notation or a Creative Commons License present in this item record.
All permission requests should be directed accordingly and not to the Sigma Repository.
All submitting authors or publishers have affirmed that when using material in their work where they do not own copyright, they have obtained permission of the copyright holder prior to submission and the rights holder has been acknowledged as necessary.
Acquisition
Proxy-submission
The Baltimore Buprenorphine Initiative: A comparison of treatment modalities for addressing heroin addiction in an urban-based community
Prague, Czech Republic
Session presented on: Friday, July 26, 2013:
Purpose: Adequate drug treatment for substance users continues to be a challenge for most United States (US) cities. In order to address heroin addiction in Baltimore, the Baltimore Buprenorphine Initiative (BBI) was implemented as a joint project to promote individualized, patient-centered buprenorphine therapy in conjunction with behavioral treatment to accelerate recovery from opioid addiction.
Methods: The BBI sample consisted of 1,039 subjects treated with buprenorphine and counseling between January 1, 2008 and June 1, 2009. Demographic and outcome variables were evaluated against two comparison groups of 8,692 patients receiving methadone treatment and 6,664 patients receiving intensive outpatient or standard outpatient (IOP-OP) treatment. Analytical methods were utilized to assess each of the three treatment groups in order to measure the simultaneous impact of a set of variables on an individual's LOS.
Results: The BBI sample consisted of 1,039 subjects treated between January 1, 2008 and June 1, 2009. Using analysis of variance, statistically significant differences among the groups were identified in three areas: age, lapse of time until admission to treatment, and length of stay in treatment. Controlling for age, gender, education, race, income, and employment, the following independent variables were used to predict LOS: lapse of time to admission, ASI scores, number of addictions, frequency of addictions, and group membership (BBI, methadone, or IOP). Demographic characteristics accounted for 15.8 % of the variance (R2 = 0.158) with the overall model explaining 42.6% of the variance surrounding the dependent variable LOS (R2=0.426). The model was statistically significant (F=223.51, df 18, 5413, p<0.001).
Conclusion: The findings of this study have practical implications for the design and implementation of heroin addiction programs. The research indicates that focusing on these specific predictive variables early in the program design phase could increase recovery success rates as measured by length of stay.